"The data that we provide include outcomes beyond the typical duration of clinical trials of blood pressure control and demonstrate the long-term safety of tighter blood pressure control, with potential benefits from a mortality standpoint in patients with known kidney disease," said Elaine Ku, Assistant Professor at University of California, San Francisco.